EN

Entero Therapeutics IncNASDAQ ENTO Stock Report

Last reporting period 31 Mar, 2024

Updated 26 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

XNAS - Nasdaq

View Section: Price ratios

Entero Statements

EN

Data from Entero`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

31 Mar, 2024

Next reporting period:

29 Jun, 2024

Report frequency:

Quarterly

Earnings release date:

13 Nov, 2024

Expected release date:

13 Nov, 2024

Entero Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-03-31
%

100

0

0

0.566

0

8.66

0

9.226

125.4 %

0

-9.226

-125.4 %

0

-0.066

0

-0.001

0

-9.292

-126.6 %

0

-14.86

0

5.501

231.7 %

0

0.384

14.511

2023-12-31
%

100

0

0

1.307

0

2.786

0

4.094

19.2 %

0

-4.094

-19.2 %

0

-0.007

0

-0.001

0

-4.101

-19.4 %

0

0

-4.178

-19.9 %

0

-5.351

0.781

2023-09-30
%

100

0

0

1.011

0

2.422

0

3.433

0

-3.433

0

-0.001

0

0

-3.434

0

0

-3.483

0

-9.208

0.378

View Section: Balance Sheet